December 21, 2022 Chemomab Reports Independent Drug Monitoring Committee Safety Review of CM-101 Phase 2 Trial in Primary Sclerosing Cholangitis View Article
December 12, 2022 Gamida Cell Announces Closing of $25 Million Financing With Highbridge View Article
December 12, 2022 PolyPid Announces Scheduling of Type D Meeting with U.S. FDA to Discuss SHIELD I Phase 3 Results and Regulatory Pathway for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery View Article
December 5, 2022 TIPA Extends Partnership With Apiece Apart, Carving a Path Towards Circular Fashion with Fully Compostable Packaging View Article
November 18, 2022 MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma View Article
October 21, 2022 Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology View Article
